Veronika Wirtz, PhD, MSc

Veronika J. Wirtz, MSc, PhD is an Associate Professor in the Department of Global Health at the Boston University School of Public Health, where she is also Director of the World Health Organization Collaborating Center in Pharmaceutical Policy. Her research focuses on health system strengthening and policy and program evaluations of medicines access and utilization. She is a Visiting Professor of the National Institute of Public Health (INSP) in Mexico and coordinator of a student exchange program between the institutions of her affiliation.

Her interest and expertise include medicines price analysis, generic medicines policies, quality use of medicines, access to medicines for non-communicable diseases and the role of the private sector to promote equitable access and efficient use of medicines in low and middle income countries. Among other international studies Dr Wirtz carried out cross-national comparison of medicines consumption using large sales data bases to inform policy making about adequate use of medicines and prevention of antimicrobial resistance.

Between 2014 and 2016 she was the Co-Chair of The Lancet Commission on Essential Medicine Policies. The Commission had the goals of (1) re-confirming the ongoing relevance, and the crucial need of comprehensive essential medicines policies to achieve broader global health and sustainable development goals, especially universal health coverage and (2) formulating recommendations for global essential medicine policies for the next two decades. The Report of the Commission Essential Medicines for Universal Coverage was published in 2016.

From 2004 to 2012 she was researcher and lecturer at the National Institute of Public Health (INSP) in Mexico and a founding member and Head of the Medicines in Public Health Research Group which is a multi-disciplinary team of 15 experts in health economics, epidemiology, social science carrying out pharmaceutical policy analysis in Mexico and Latin America. Over the last years she has regularly taught short courses in Pharmacoepidemiology and Medicines Utilization Research at INSP in Mexico.

She has worked as a technical adviser for various international organizations, among them the World Health Organization, the Pan American Health Organization, the Global Fund to fight AIDS, Tuberculosis and Malaria, the Bill and Melinda Gates Foundation, Alliance for Health Systems and Policy Research, Health Action International and the Ford Foundation. She has also worked with the Ministry of Health in Mexico on various program evaluations and capacity building initiatives. She published widely in international peer review journals such as The Lancet, British Medical Journal, World Health Organization Bulletin, Health Policy and Planning, Health Policy, Value in Health, Social Science and Medicine, Tropical Medicine and International Health. Since Fall 2016 she is Associate Editor of Health Systems & Reform, a leading journal publishing health system and policy research.

She received her training as a pharmacist from Albert-Ludwigs-University in Freiburg, Germany and her Master in Clinical Pharmacy and PhD from the University of London in the UK.

2014-2016 The Lancet Commission on Essential Medicines Policies: Co-Chair
2009-2014 National System of Researchers (SNI), National Council for Science and Technology, Mexico : Member
2009-2010 Coordinating Commission of the National Institutes of Health and Tertiary Hospitals, Mexico: Excellence in Research Productivity
2007 Research Conference of the National Institutes of Health and Tertiary Hospitals, Mexico: Nominee for Best Research Presentation
2007-2009 National System of Researchers (SNI), National Council for Science and Technology, Mexico: Awarded Membership as Candidate
1999-2004 School of Pharmacy, University of London: PhD Studies Scholarship


SIAPS
10/01/2015 - 02/28/2018 (PI)
Management Sciences for Health USAID


Novartis Access Initiative Task Order 3
10/01/2016 - 12/31/2017 (Co-PI)
PI: Richard Laing, MBChB, MSc (CHDC) MD
Sandoz International GmbH


Novartis Access Initiative Task Order 2
04/29/2016 - 09/30/2017 (Co-PI)
PI: Richard Laing, MBChB, MSc (CHDC) MD
Sandoz International GmbH


Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS) Study
03/17/2017 - 08/31/2017 (PI)
Health Action International Leona&Harry Helmsley


Quality of Medical Products & Public Health Course
07/10/2017 - 07/14/2017 (PI)
Medicines for Malaria Ventures


Novartis Access Initiative Task Order 1
12/01/2015 - 04/30/2017 (Co-PI)
PI: Richard Laing, MBChB, MSc (CHDC) MD
Sandoz International GmbH


The Lancet Commission on Essential Medicine Policies
02/20/2015 - 09/30/2016 (PI)
Bill and Melinda Gates Foundation





Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Vogler S, Paris V, Ferrario A, Wirtz VJ, de Joncheere K, Schneider P, Pedersen HB, Dedet G, Babar ZU. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. Appl Health Econ Health Policy. 2017 Jun; 15(3):307-321. PMID: 28063134; DOI: 10.1007/s40258-016-0300-z;.
  2. Kaplan WA, Ashigbie PG, Brooks MI, Wirtz VJ. Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies. J Pharm Policy Pract. 2017; 10:17.View Related Profiles. PMID: 28523128.
  3. Wirtz VJ, Hogerzeil HV, Gray AL. Essential medicines for universal health coverage - Authors'' reply. Lancet. 2017 May 13; 389(10082):1881-1882. PMID: 28513447.
  4. Rockers PC, Wirtz VJ, Umeh CA, Swamy PM, Laing RO. Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence. Health Aff (Millwood). 2017 Apr 01; 36(4):706-713.View Related Profiles. PMID: 28373337; DOI: 10.1377/hlthaff.2016.1213;.
  5. Rockers PC, Wirtz VJ, Vian T, Onyango MA, Ashigbie PG, Laing R. Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya. BMJ Open. 2016 Nov 25; 6(11):e013386.View Related Profiles. PMID: 27888177; DOI: 10.1136/bmjopen-2016-013386;.
  6. Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, ''t Hoen EF, Wagner AK, Yadav P, Reich MR. Essential medicines for universal health coverage. Lancet. 2017 Jan 28; 389(10067):403-476. PMID: 27832874; DOI: 10.1016/S0140-6736(16)31599-9;.
  7. Manne-Goehler J, Umeh CA, Montgomery SP, Wirtz VJ. Estimating the Burden of Chagas Disease in the United States. PLoS Negl Trop Dis. 2016 Nov; 10(11):e0005033. PMID: 27820837; DOI: 10.1371/journal.pntd.0005033;.
  8. Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries". Circulation. 2016 Oct 04; 134(14):e305-e306.View Related Profiles. PMID: 27698055.
  9. Roche SD, Ketheeswaran P, Wirtz VJ. International short-term medical missions: a systematic review of recommended practices. Int J Public Health. 2017 Jan; 62(1):31-42. PMID: 27592359; DOI: 10.1007/s00038-016-0889-6;.
  10. Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Leufkens HG, Wirtz VJ. Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis. Health Policy Plan. 2016 Nov; 31(9):1291-6. PMID: 27229872; DOI: 10.1093/heapol/czw066;.
Showing 10 of 78 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 78 publications over 14 distinct years, with a maximum of 14 publications in 2013

YearPublications
20032
20041
20053
20072
20087
20093
20105
20113
201211
201314
20145
20158
201610
20174
Contact for Mentoring:


801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Wirtz's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department